Structure and functions of transcriptional coactivators p300/CBP and their roles in regulation of interleukin gene expression

Chinese Science Bulletin

Volumn 49, Issue 24, 2004, Pages 2555-2562

  Shao, Yangguang ^a   Zhang, Guoping ^a   Lu, Jun ^a   Huang, Baiqu ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Cancer; Interleukin; P300 CBP; Transcriptional coactivators; Transcriptional regulation

Indexed keywords

EID: 33749685353     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1360/982004-349     Document Type: Review

References (47)

1. Chrivia, J. C., Kwok, R. P., Lamb, N. et al., Phosphorylated CREB binds specifically to the nuclear protein CBP, Nature, 1993, 365: 855-859.
2. Eckner, R., Ewen, M. E., Newsome, D. et al., Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor, Genes Dev., 1994, 8: 869-884.
3. Giordano, A., Avantaggiati, L. M., p300 and CBP: Partners for life and death, J. Cell. Physiol., 1999, 181: 218-230.
4. Polesskaya, A., Naguibneva, I., Duquel, A. et al., Interaction between acetylated MyoD and the bromodomain of CBP and/or p300, Mol. Cell Biol., 2001, 21: 5312-5320.
5. Chan, M. H., La Thangue, B. N., p300/CBP proteins: HATs for transcriptional bridges and scaffolds, J. Cell Sci., 2001, 114: 2363-2373.
6. Blobel, G. A., CBP/p300: Molecular integrators of hematopoietic transcription, Blood, 2000, 95(3): 745-755.
7. Munshi, N., Merika, M., Yie, J. et al., Acetylation of HMG I (Y) by CBP turns off IFNβ expression by disrupting the enhanceosome, Mol. Cell, 1998, 2: 457-467.
8. Sterner, E. D., Berger, L. S., Acetylation of histones and transcription-related factors, Microbiol. Mol. Biol., 2000, 64: 435-459.
9. Muth, V., Nadaud, S., Grummt, I. et al., Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription, EMBO J., 2001, 20: 1353-1362.
10. Giles, R. H., Peters, D. J., Breuning, M. H., Conjunction dysfunction: CBP/p300 in human disease, Trends Genet., 1998, 14(5): 178 -183.
11. Goodman, R. H., Smolik, S., CBP/p300 in cell growth, transformation, and development, Genes Dev., 2000, 14: 1553-1577.
12. Banerjee, A. C., Recupero, A. J., Mal, A. et al., The adenovirus E1A 289R and 243R proteins inhibit the phosphorylation of p300, Oncogene, 1994, 9: 1733-1737.
13. Perkins, N. D., Felzien, L. K., Betts, J. C. et al., Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator, Science, 1997, 275: 523-527.
14. Ait-Si-Ali, S., Ramirez, S., Barre, F. X. et al., Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A, Nature, 1998, 396: 184-186.
15. Wang, H. G. H., Moran, E., Yacuik, P., E1A promotes association between p300 and pRb in multimeric complexes required for normal biological activity, J. Virol., 1995, 69: 7917-7924.
16. Hottiger, M. O., Nabel, G. J., Viral replication and the coactivators p300 and CBP, Trends Microbiol., 2000, 8(12): 560-565.
17. Hamamori, Y., Sartorelli, V., Ogryzko, V., et al. Regulation of histone acetyltransferases p300 and pCAF by the bHLH protein twist and adenoviral oncoprotein E1A, Cell, 1999, 96: 405-413.
18. Blobel, G. A., Nakajima, T., Eckner, R. et al., CREB-binding protein (CBP) cooperates with transcription factor GATA-1 and is required for erythroid differentiation, Proc. Natl Acad. Sci. USA, 1998, 95: 2061-2066.
19. Zhang, W., Bieker, J. J., Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases, Proc. Natl. Acad. Sci. USA, 1998, 95: 9855-9860.
20. Bradney, C., Hjelmeland, M., Komatsu, Y. et al., Regulation of E2A activities by histone acetyltransferases in B lymphocyte development, J. Biol. Chem., 2003, 278(4): 2370-2376.
21. Snowden, W. A., Perkins, D. N., Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein, Biochem. Pharmacol., 1998, 55: 1947-1954.
22. Vojtek, A. B., Taylor, J., DeRuiter, S. L., Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation, Mol. Cell Biol., 2003, 23(13): 4417-4427.
23. Jang, S. I., Steinert, P. M., Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families, J. Biol. Chem., 2002, 277(44): 42268-42279.
24. Grossman, S. R., Perez, M., Kung, A. L. et al., p300/MDM2 complexes participate in MDM2-mediated p53 degradation, Mol. Cell, 1998, 2: 405-415.
25. Wang, X., Taplick, J., Geva, N. et al., Inhibition of p53 degradation by Mdm2 acetylation, FEBS Lett., 2004, 561(1-3): 195-201.
26. Petrij, F., Giles, R. H., Dauwerse, H. G. et al., Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP, Nature, 1995, 376: 348-351.
27. Gayther, S. A., Batley, S. J., Linger, L. et al., Mutations truncating the EP300 acetylase in human cancers, Nat. Genet., 2000, 24: 300 -303.
28. Janknecht, R., The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease, Histol. Histopathol., 2002, 17(2): 657-668.
29. Panagopoulos, I., Fioretos, T., Isaksson, M. et al., Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum. Mol. Genet., 2001, 10: 395-404.
30. Taki, T., Sako, M., Tsuchida, M. et al., The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene, Blood, 1997, 89: 3945-3950.
31. Ida, K., Kitabayashi, I., Taki, T. et al., Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13), Blood, 1997, 90: 4699-4704.
32. Kitabayashi, I., Aikawa, Y., Yokoyama, A. et al., Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22) (p11;q13) chromosome translocation, Leukemia, 2001, 15: 89-94.
33. Li, F., Macfarlan, T., Pittman, R. N. et al., Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities, J. Biol. Chem., 2002, 277(47): 45004-45012.
34. Avots, A., Buttmann, M., Chuvpilo, S. et al., CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation, Immunity, 1999, 10: 515-524.
35. Sisk, T. J., Gourley, T., Roys, S. et al., MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300, J. Immunol., 2000, 165: 2511-2517.
36. vanden Berghe, W., de Bosscher, K., Boone, E. et al., The nuclear factor-κβ engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter, J. Biol. Chem., 1999, 274: 32091-32098.
37. Huang, S. M., McCance, D. J., Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF, J. Virol., 2002, 76: 8710-8721.
38. Yamashita, M., Ukai-Tadenuma, M., Kimura, M. et al., Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus, J. Biol. Chem., 2002, 277: 42399-42408.
39. Bannen, N., Avots, A., Baier, M. et al., GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin-16 promoter in T lymphocytes, Proc. Natl. Acad. Sci. USA, 1999, 96: 1541-1546.
40. Liu, C., Lu, J., Li, L. et al., Coactivator CBP/p300 increased the activity of C/EBP-mediated human interleukin-5 gene promoter, Chinese Science Bulletin, 2004, 49 (6): 574-578.
41. Liu, C., Lu, J., Tan, J. et al., Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1, Cytokine, 2004, 27: 93-100.
42. Sun, H., Lu, J., Wei, L. et al., Histone acetyltransferase activity of p300 enhances the activation of IL-12 p40 promoter, Mol. Immunol., 2004, 41 (12): 1241-1246.
43. Sun, H., Lu, J., Xu, X. et al., Reversible histone acetylation /deacetylation modification by p300 and HDAC3 is involved in the regulation of IL-18 promoter activity, Chinese Science Bulletin, 2004, 49(11): 1151-1156.
44. Serrador, J. M., Cabrero, J. R., Sancho, D. et al., HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization, Immunity, 2004, 20 (4): 417-428.
45. Valapour, M., Guo, J., Schroeder, J. T. et al., Histone deacetylation inhibits IL4 gene expression in T cells, J. Allergy Clin. Immunol., 2002, 109 (2): 238-245.
46. Ito, K., Hanazawa, T., Tomita, K. et al., Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: Role of tyrosine nitration, Biochem. Biophys. Res. Commun., 2004, 315(1): 240-245.
47. Ashburner, B. P., Westerheide, S. D., Baldwin, A. S. Jr., The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression, Mol. Cell Biol., 2001, 21 (20): 7065-7077.